US2012100189A1PendingUtilityA1
Delayed release rasagiline malate formulation
Est. expiryJan 23, 2029(~2.5 yrs left)· nominal 20-yr term from priority
A61P 9/10A61P 25/00A61P 25/16A61P 25/28A61P 25/18A61P 25/24C07C 211/42A61K 9/2054A61K 31/135C07C 59/265C07C 2602/08A61K 9/2886A61K 9/2059A61K 9/2846A61K 9/2893A61K 9/2018A61K 9/2013
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.
Claims
exact text as granted — not AI-modified1 .- 36 . (canceled)
37 . A stable oral dosage form comprising a core having rasagiline malate and at least one pharmaceutically acceptable excipient; and an acid resistant pharmaceutically acceptable coating.
38 . A stable oral dosage form comprising a core having rasagiline base and at least one pharmaceutically acceptable excipient; and an acid resistant pharmaceutically acceptable coating.
39 . Rasagiline citrate.Join the waitlist — get patent alerts
Track US2012100189A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.